- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 271/06 - Esters des acides carbamiques
Détention brevets de la classe C07C 271/06
Brevets de cette classe: 51
Historique des publications depuis 10 ans
|
2
|
1
|
3
|
3
|
1
|
4
|
5
|
1
|
3
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Soprema | 91 |
4 |
| Glioblastoma Foundation, Inc. | 7 |
3 |
| BASF SE | 21320 |
2 |
| Colgate-Palmolive Company | 5733 |
2 |
| FUJIFILM Corporation | 30628 |
2 |
| Asahi Kasei Chemicals Corporation | 544 |
2 |
| Relay Therapeutics, Inc. | 85 |
2 |
| Lantern Pharma Inc. | 94 |
2 |
| Inkbit, LLC | 77 |
2 |
| Chorda Pharma, Inc. | 8 |
2 |
| Boehringer Ingelheim International GmbH | 4485 |
1 |
| Bayer MaterialScience AG | 704 |
1 |
| Dow Global Technologies LLC | 11008 |
1 |
| The General Hospital Corporation | 4879 |
1 |
| Mitsui Chemicals, Inc. | 3262 |
1 |
| Axalta Coating Systems IP Co., LLC | 478 |
1 |
| Barclays Bank plc, AS Successor Agent | 119 |
1 |
| The Brigham and Women's Hospital, Inc. | 2299 |
1 |
| BYK-Chemie GmbH | 447 |
1 |
| Concert Pharmaceuticals, Inc. | 242 |
1 |
| Autres propriétaires | 18 |